Suyash Prasad, M.B.B.S, F.F.P.M
2020
In 2020, Suyash Prasad, M.B.B.S, F.F.P.M earned a total compensation of $4M as Chief Medical Officer and Head of Research and Development at Taysha Gene Therapies.
Compensation breakdown
Non-Equity Incentive Plan | $129,975 |
---|---|
Salary | $216,833 |
Stock Awards | $3,668,409 |
Other | $152 |
Total | $4,015,369 |
FFPM received $3.7M in stock awards, accounting for 91% of the total pay in 2020.
FFPM also received $130K in non-equity incentive plan, $216.8K in salary and $152 in other compensation.
Rankings
In 2020, Suyash Prasad, M.B.B.S, F.F.P.M's compensation ranked 2,838th out of 13,090 executives tracked by ExecPay. In other words, FFPM earned more than 78.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 2,838 | 78th |
Manufacturing | 1,090 | 81st |
Chemicals And Allied Products | 402 | 82nd |
Drugs | 346 | 82nd |
Biological Products, Except Diagnostic Substances | 92 | 78th |
FFPM's colleagues
We found two more compensation records of executives who worked with Suyash Prasad, M.B.B.S, F.F.P.M at Taysha Gene Therapies in 2020.